UNRAVELLING ATRIAL FIBRILLATION AETIOLOGY AND ANTICOAGULATION TRENDS IN STROKE. WHERE DO WE STAND? A STUDY FROM

Farhat Naz1, Saqib Malik1, Khazima Asif1

  • 1Department of Medicine, Ayub Medical College, Abbottabad-Pakistan.

Insights

Atrial Fibrillation (AF) is a common cause of stroke. Identifying and managing risk factors like heart disease, hyperlipidemia, smoking, and respiratory issues is crucial for stroke prevention through primary prevention and anticoagulation.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Atrial Fibrillation (AF) is a prevalent cardiac arrhythmia linked to increased stroke risk.
  • Numerous modifiable risk factors contribute to AF, highlighting opportunities for primary prevention.
  • Early identification of AF and its associated risk factors is essential for effective stroke prevention strategies, including anticoagulation therapy.

Purpose of the Study:

  • To determine the frequency of Atrial Fibrillation (AF) among stroke patients.
  • To identify significant risk factors associated with AF in this population.
  • To assess the prior anticoagulation status of patients diagnosed with AF.

Main Methods:

  • A cross-sectional observational study was conducted on 160 stroke patients.
  • Data collected included patient demographics, stroke type, AF diagnosis, and presence of various risk factors.
  • Statistical analysis, including Chi-square tests, was employed to correlate risk factors with AF.

Main Results:

  • Atrial Fibrillation (AF) was identified in 32 (20%) of the 160 stroke patients.
  • Hypertension (85%), ischemic heart disease (32.5%), hyperlipidemia (23.1%), and smoking (11.9%) were common risk factors.
  • Only 25% of patients with AF had received prior anticoagulation therapy.

Conclusions:

  • Ischemic heart disease, hyperlipidemia, smoking, and chronic respiratory disease are significantly associated with Atrial Fibrillation (AF) in stroke patients.
  • These identified risk factors are modifiable, underscoring the importance of primary prevention strategies.
  • Emphasis on prophylactic anticoagulation is recommended for patients with AF to mitigate stroke risk.
Abstract